Keywords: medarex, mdx-33, plasma, protein, leader, centeon, agreed

Medarex' MDX-33

Article | 13 May 1996

- Plasma protein leader Centeon and Medarex have agreed to develop jointly Medarex' MDX-33, a humanized monoclonal antibody for the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in